Bioventus (BVS) Research & Development (2020 - 2026)
Bioventus' (BVS) quarterly Research & Development came in at $2.5 million in Q1 2026, down 18.07% YoY from $3.0 million in Q1 2025, and down 17.96% on a QoQ basis from $3.0 million in Q4 2025.
Bioventus (BVS) Research & Development (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Research & Development data on file, last reported at $2.5 million in Q1 2026.
- Quarterly Research & Development fell 18.07% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.6 million (down 19.3% YoY) and the FY2025 annual result came in at $12.1 million, down 13.17% from the prior year.
- Research & Development fell to $2.5 million in Q1 2026, from $3.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $6.9 million in Q2 2022 to a low of $2.5 million in Q1 2026.
- A 5-year average of $3.9 million and a median of $3.3 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development soared 631.57% — and 2023, when it slumped 46.62%.
- Tracing BVS's Research & Development over 5 years: stood at $5.9 million in 2022, then sank by 45.14% to $3.3 million in 2023, then increased by 0.28% to $3.3 million in 2024, then retreated by 8.07% to $3.0 million in 2025, then dropped by 17.96% to $2.5 million in 2026.
- The last three Research & Development figures came in at $2.5 million (Q1 2026), $3.0 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Bioventus | 970.53 Mn | 941.07 Mn | 105.67 Mn | 3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 3.17 Mn |
| Mar 28, 2026 | 2.47 Mn |
| Dec 31, 2025 | 3.01 Mn |
| Sep 27, 2025 | 2.92 Mn |
| Jun 28, 2025 | 3.17 Mn |
| Mar 29, 2025 | 3.01 Mn |
| Dec 31, 2024 | 3.27 Mn |
| Sep 28, 2024 | 3.84 Mn |
| Jun 29, 2024 | 4.21 Mn |
| Mar 30, 2024 | 2.63 Mn |
| Dec 31, 2023 | 3.26 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jul 1, 2023 | 3.40 Mn |
| Apr 1, 2023 | 3.77 Mn |
| Dec 31, 2022 | 5.95 Mn |
| Oct 1, 2022 | 4.61 Mn |
| Jul 2, 2022 | 6.37 Mn |
| Apr 2, 2022 | 6.93 Mn |
| Dec 31, 2021 | 7.10 Mn |
| Oct 2, 2021 | 6.15 Mn |